economic impact of dengue episode: multicenter study ... · •increased number of reported dengue...
TRANSCRIPT
Economic impact of dengue episode: multicenter study across four Brazilian regions
First Regional Dengue SymposiumRio de Janeiro, November 2015
Celina Maria Turchi MartelliVisiting Researcher - CPqAM / Fiocruz-Pernambuco
2003:517 thousand 2009-2012: 1 million 2013: > 2 million
Brazil
Mexico
Colombia
Venezuela
Four countries registered 80% of dengue cases
Dengue in America, 2006 -2014
J.L. San Martin / OPAS
Background
• Increased number of reported dengue cases in Brazil
• Cost studies in Brazil and Guideline: – Cost of dengue cases in eight countries in the Americas and Asia (Suaya et al, 2009)
– Direct costs of dengue hospitalization in Brazil (Vieira, 2014)
– Guideline for Costing dengue cases and outbreaks (2012)
Rev Panam Salud Publica 34(3), 2013
Economic impact of dengue episode in Brazil
Objective: To evaluate the economic burden of dengue from
the public payer and societal perspectives
Sponsor: Sanofi Pasteur
Institution: University of Pernambuco, Brazil
Ethical clearance at national level: CONEP
• Cohort: probable dengue cases
• Ambulatory/hospitalized
• Health System: Sectors
Public and Private
Perspectives:
Public Payer: Direct medical costs
Societal:Direct cost, direct non-medical costs, indirect costsDeaths
• Period of study: dengue transmission – high/low
Methods - Study Design
Study sites in Brazil
TeresinaRecife Coordinator Center
Rio de Janeiro
Belo Horizonte
Goiânia
Belém
CityPopulation
(million)Incidence, 2013
(1,000 inhab.)
Goiania 1,2 50.1Belo Horizonte 2,4 55.3Rio de Janeiro 6,3 11.8Teresina 1,2 2.2Recife 1,5 2.7Belem 1,4 1.3
Teresina Recife
Rio de Janeiro Belo HorizonteGoiânia
Belém
Methods - Interviews and Data management
• Phase 1. Hospital/ambulatory settings – recruitment of patients, to
obtain informed consent and schedule household interviews
• Phase 2. Household interview – 15-20 days after the onset of
clinical symptoms
Quanto custa a Dengue para
você e para a sociedade?
Caso seja solicitado, colabore.
Methods - Data collection
• Questionnaire: multi-country cost study (Suaya et al, 2009)
• Patients interview: date of symptoms/signs, use of medical service,
work/school absence, out-of-pocket expenses
• Hospitalized patients: data extracted from the patient´s file
Methods - Costing dengue episode
• Ambulatory and hospital settings, public and private sectors
• Unit cost for medical visit for outpatients
• Public sector - SUS value (USD 4.85)
• Private sector - private health insurance value (USD 26.45)
• Direct cost of hospitalized patients: cost and resource use
2,223 screened dengue cases
188 cases excluded
2,035 dengue cases
1,657 Ambulatory cases
378 Hospitalized cases
Public sectorn=1,144
Private sectorn=513
Public sectorn=217
Private sectorn=161
Public payer perspectiveDirect costs
Societal perspectivePublic and Private sectorsDirect and Indirect costs
Household interview
Flowchart of the study
Dengue epidemiology in Brazil - September 2012 - August 2013
Health care access, Brazil 2013
0
10
20
30
40
50
60
70
80
90
100
D+E C2 C1 B2 B1 A1+A2He
alth
car
e a
cce
ss (
%)
Economic classes
Public
Private
Cost per hospitalized dengue case (2013 US$)
Cost distribution of dengue episode (2013 US$)Ambulatory
Hospital
Public payer perspective
Without Expansion Factor With Expansion Factor
Ambulatory 1.8 million cases 5.8 million cases (EF=3.2)
Direct cost per case $ 64 (48-80) unit cost
Cost $ 116 million (87-145) $ 371 million (278-464)
Hospital 201 thousand cases 322 thousand cases (EF=1.6)
Direct cost per case $ 237 (177-297) unit cost
Cost $ 48 million (36-60) $ 76 million (57-96)
Total cost $ 164 million (123-205) $ 447 million (335-560)
Societal perspective
Without Expansion Factor With Expansion Factor
Ambulatory 1.8 million cases 5.8 million cases (EF=3.2)
Cost per case $ 173 (129-218) unit cost
Cost $ 313 million (234-395) $ 1,003 million (748-1,264)
Hospital 201 thousand cases 322 thousand cases (EF=1.6)
Cost per case $ 448 (333-562) unit cost
Cost $ 90 million (67-113) $ 144 million (107-181)
Total cost $ 404 million (301-508) $ 1,147 million (855-1,445)
Number of fatal cases 529 (395-665)
Fatal costs $ 65 million (48-81)
Grand total cost $ 468 million (349-590) $ 1,212 million (904-1,526)
Estimated costs of dengue in Brazil (2013 US$)
Estimated cost of dengue 2009–2013 (2013 US$)
AcknowlegmentsUniversidade de Pernambuco - UPE
Centro de Pesquisa Aggeu Magalhães – Fiocruz/PE
Universidade Federal de Goiás - UFG
Universidade Estadual do Piauí - UESPI
Universidade do Estado do Rio de Janeiro – UERJ
Secretaria Municipal de Belo Horizonte- SMBH
Universidade do Estado do Pará – UEPA
Institute of Health Technology - IATS
Fellowships Grants CNPq
Sanofi Pasteur for support
Researcher Team
Celina Maria Turchi MartelliJoão Bosco Siqueira JuniorMirian Perpetua Palha Dias ParenteAna Laura de Sene Amancio ZaraConsuelo Silva OliveiraCynthia BragaFabiano Geraldo Pimenta JuniorFanny CortesLuciana Ribeiro BahiaMárcia Costa Ooteman MendesMichelle Quarti Machado RosaNoêmia Teixeira Siqueira FilhaWayner Vieira Souza
Dagna ConstenlaJuan Guillermo Lopez
Halasa et al, 2012 EF = 10 EF = 2.42 EF ambulatory : 5 - 27
Wettstein et al, 2012
Epidemic period EF = 10 cases DF (variation: 8-14) Probabilistic (Monte
Carlo simulation),
univariate
Endemic period EF = 20 (variation: 18-25)
DHF cases, EF = 6 (variation 5-10)
Suaya et al, 2009 EF = 3 EF = 3 Univariate (EF 2, 3 e 6)
Shepard et al, 2011Brazil EF = 5 ; Colombia EF = 9 ; Nicaragua EF = 20,4 ;
Panama EF = 6 ; Puerto Rico & other countries EF = 15
Brazil EF = 1.6 ; Colombia,
Panama & Nicaragua EF =
2.3 ; Puerto Rico EF = 2.4 ;
Other countries EF = 2.3
Probabilistic. Monte
Carlo simulation
Author, year of
publicationEF ambulatory EF hospital Sensitivity analysis
Armien et al, 2008 EF = 6 EF = 6 Univariate (EF 1-10)
Cost per ambulatory dengue case (2013 US$)
Cost of illness Americas
Ambulatory Hospital
Medical Non-medical Indirect Total I$, 2014
Brazil
El Salvador
Guatemala
PanamaVenezuela
Venezuela
Venezuela
Argentina
Cuba
Colombia
Puerto Rico
Nicaragua
Brazil
Brazil